Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Immunic Inc’s stock clocked out at $0.82, up 1.94% from its previous closing price of $0.80. In other words, the price has increased by $1.94 from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
To gain a deeper understanding of IMUX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.74.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 13 ’25 when Nash Duane bought 20,000 shares for $0.83 per share. The transaction valued at 16,694 led to the insider holds 36,032 shares of the business.
Tardio Jason bought 12,512 shares of IMUX for $9,884 on Jun 05 ’25. The President and COO now owns 12,512 shares after completing the transaction at $0.79 per share. On Jun 04 ’25, another insider, Vitt Daniel, who serves as the CEO and Director of the company, bought 15,000 shares for $0.77 each. As a result, the insider paid 11,550 and bolstered with 29,000 shares of the company.
Stock Price History:
Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -13.13%, while the 200-Day Moving Average is calculated to be -29.06%.
Shares Statistics:
A total of 95.82M shares are outstanding, with a floating share count of 92.56M. Insiders hold about 3.40% of the company’s shares, while institutions hold 40.58% stake in the company.
